Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody
Researchers from BIOMED Division at LEITAT Technological Center, in collaboration with the University of Barcelona, demonstrated the efficacy of a
Researchers from BIOMED Division at LEITAT Technological Center, in collaboration with the University of Barcelona, demonstrated the efficacy of a
Horizon 2020, the EU’s new programme for investment in research and innovation, is expected to dedicate more than 7 billion

Boosting Health Sector to reduce its environmental impact using an innovative decision-making process based on LCA/LCC
Integration of Novel NANOparticle based technology for THERapeutics and diagnosi of different types of cancer.
Tel. (+34) 937 882 300
Utilitzem cookies per millorar la teva experiència de navegació, publicar anuncis o contingut personalitzats i analitzar el nostre trànsit. En fer clic a "Acceptar-ho tot", acceptes l'ús que fem de les cookies.